nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—rheumatoid arthritis—Gabapentin—epilepsy syndrome	0.233	1	CpDpCtD
Indomethacin—SLCO1A2—epilepsy syndrome	0.103	0.42	CbGaD
Indomethacin—ABCC2—epilepsy syndrome	0.0493	0.201	CbGaD
Indomethacin—CYP2C19—epilepsy syndrome	0.0342	0.14	CbGaD
Indomethacin—CES1—Rufinamide—epilepsy syndrome	0.0281	0.0894	CbGbCtD
Indomethacin—PTGS2—epilepsy syndrome	0.0213	0.087	CbGaD
Indomethacin—ALB—epilepsy syndrome	0.019	0.0775	CbGaD
Indomethacin—ABCB1—epilepsy syndrome	0.0181	0.074	CbGaD
Indomethacin—UGT2B7—Carbamazepine—epilepsy syndrome	0.0157	0.05	CbGbCtD
Indomethacin—ABCC3—Phenobarbital—epilepsy syndrome	0.0146	0.0463	CbGbCtD
Indomethacin—ABCC2—Levetiracetam—epilepsy syndrome	0.0144	0.0458	CbGbCtD
Indomethacin—UGT1A9—Propofol—epilepsy syndrome	0.0139	0.0442	CbGbCtD
Indomethacin—UGT1A1—Propofol—epilepsy syndrome	0.0114	0.0362	CbGbCtD
Indomethacin—UGT1A9—Valproic Acid—epilepsy syndrome	0.00994	0.0316	CbGbCtD
Indomethacin—UGT2B7—Valproic Acid—epilepsy syndrome	0.00941	0.0299	CbGbCtD
Indomethacin—ABCC1—Phenobarbital—epilepsy syndrome	0.00894	0.0284	CbGbCtD
Indomethacin—SLC22A7—Valproic Acid—epilepsy syndrome	0.00851	0.027	CbGbCtD
Indomethacin—ABCC2—Carbamazepine—epilepsy syndrome	0.00828	0.0263	CbGbCtD
Indomethacin—ALB—Oxcarbazepine—epilepsy syndrome	0.00822	0.0261	CbGbCtD
Indomethacin—ABCC2—Phenytoin—epilepsy syndrome	0.00743	0.0236	CbGbCtD
Indomethacin—ALB—Fosphenytoin—epilepsy syndrome	0.00718	0.0228	CbGbCtD
Indomethacin—ABCC2—Phenobarbital—epilepsy syndrome	0.00662	0.021	CbGbCtD
Indomethacin—ALB—Clonazepam—epilepsy syndrome	0.0065	0.0206	CbGbCtD
Indomethacin—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.00533	0.0169	CbGbCtD
Indomethacin—ALB—Rufinamide—epilepsy syndrome	0.00529	0.0168	CbGbCtD
Indomethacin—PTGS1—Diazepam—epilepsy syndrome	0.00524	0.0166	CbGbCtD
Indomethacin—SLC22A8—Valproic Acid—epilepsy syndrome	0.0052	0.0165	CbGbCtD
Indomethacin—CYP2C19—Felbamate—epilepsy syndrome	0.00495	0.0157	CbGbCtD
Indomethacin—CYP2C19—Trimethadione—epilepsy syndrome	0.00495	0.0157	CbGbCtD
Indomethacin—SLC22A6—Acetazolamide—epilepsy syndrome	0.00484	0.0154	CbGbCtD
Indomethacin—ABCB1—Levetiracetam—epilepsy syndrome	0.0047	0.0149	CbGbCtD
Indomethacin—CYP2C19—Fosphenytoin—epilepsy syndrome	0.00466	0.0148	CbGbCtD
Indomethacin—ALB—Phenytoin—epilepsy syndrome	0.00463	0.0147	CbGbCtD
Indomethacin—ALB—Propofol—epilepsy syndrome	0.00432	0.0137	CbGbCtD
Indomethacin—PTGS1—Valproic Acid—epilepsy syndrome	0.00413	0.0131	CbGbCtD
Indomethacin—CYP2C9—Trimethadione—epilepsy syndrome	0.00412	0.0131	CbGbCtD
Indomethacin—CYP2C19—Clobazam—epilepsy syndrome	0.00404	0.0128	CbGbCtD
Indomethacin—ALB—Diazepam—epilepsy syndrome	0.00391	0.0124	CbGbCtD
Indomethacin—CYP2C9—Fosphenytoin—epilepsy syndrome	0.00387	0.0123	CbGbCtD
Indomethacin—SLC22A6—Valproic Acid—epilepsy syndrome	0.00362	0.0115	CbGbCtD
Indomethacin—CYP2C19—Carbamazepine—epilepsy syndrome	0.00335	0.0106	CbGbCtD
Indomethacin—ABCB1—Clobazam—epilepsy syndrome	0.00326	0.0103	CbGbCtD
Indomethacin—ABCB1—Lamotrigine—epilepsy syndrome	0.00314	0.00996	CbGbCtD
Indomethacin—CYP2C19—Primidone—epilepsy syndrome	0.00312	0.00992	CbGbCtD
Indomethacin—CYP2C19—Phenytoin—epilepsy syndrome	0.003	0.00953	CbGbCtD
Indomethacin—CYP2C19—Propofol—epilepsy syndrome	0.0028	0.00889	CbGbCtD
Indomethacin—CYP2C9—Carbamazepine—epilepsy syndrome	0.00278	0.00884	CbGbCtD
Indomethacin—ABCB1—Carbamazepine—epilepsy syndrome	0.0027	0.00858	CbGbCtD
Indomethacin—CYP2C19—Phenobarbital—epilepsy syndrome	0.00267	0.0085	CbGbCtD
Indomethacin—CYP2C9—Primidone—epilepsy syndrome	0.0026	0.00825	CbGbCtD
Indomethacin—CYP2C19—Diazepam—epilepsy syndrome	0.00254	0.00805	CbGbCtD
Indomethacin—CYP2C9—Phenytoin—epilepsy syndrome	0.00249	0.00793	CbGbCtD
Indomethacin—CYP2C19—Zonisamide—epilepsy syndrome	0.00247	0.00786	CbGbCtD
Indomethacin—ABCB1—Phenytoin—epilepsy syndrome	0.00242	0.00769	CbGbCtD
Indomethacin—CYP2C9—Propofol—epilepsy syndrome	0.00233	0.00739	CbGbCtD
Indomethacin—CYP2C9—Phenobarbital—epilepsy syndrome	0.00222	0.00706	CbGbCtD
Indomethacin—ABCB1—Phenobarbital—epilepsy syndrome	0.00216	0.00686	CbGbCtD
Indomethacin—ABCB1—Midazolam—epilepsy syndrome	0.00213	0.00676	CbGbCtD
Indomethacin—CYP2C9—Diazepam—epilepsy syndrome	0.00211	0.0067	CbGbCtD
Indomethacin—ABCB1—Diazepam—epilepsy syndrome	0.00205	0.0065	CbGbCtD
Indomethacin—CYP2C19—Valproic Acid—epilepsy syndrome	0.002	0.00635	CbGbCtD
Indomethacin—CYP2C19—Topiramate—epilepsy syndrome	0.0018	0.00573	CbGbCtD
Indomethacin—CYP2C9—Valproic Acid—epilepsy syndrome	0.00166	0.00528	CbGbCtD
Indomethacin—PLA2G2A—tongue—epilepsy syndrome	0.00108	0.0457	CbGeAlD
Indomethacin—PPARG—forelimb—epilepsy syndrome	0.00104	0.0439	CbGeAlD
Indomethacin—PTGDR2—cerebellum—epilepsy syndrome	0.000616	0.0259	CbGeAlD
Indomethacin—PTGR2—medulla oblongata—epilepsy syndrome	0.000578	0.0244	CbGeAlD
Indomethacin—PTGR2—midbrain—epilepsy syndrome	0.000529	0.0223	CbGeAlD
Indomethacin—PTGR2—spinal cord—epilepsy syndrome	0.000516	0.0217	CbGeAlD
Indomethacin—PTGDR2—brain—epilepsy syndrome	0.0005	0.0211	CbGeAlD
Indomethacin—GLO1—forebrain—epilepsy syndrome	0.000495	0.0208	CbGeAlD
Indomethacin—PTGR2—head—epilepsy syndrome	0.000458	0.0193	CbGeAlD
Indomethacin—GLO1—telencephalon—epilepsy syndrome	0.000455	0.0191	CbGeAlD
Indomethacin—PTGR2—nervous system—epilepsy syndrome	0.000435	0.0183	CbGeAlD
Indomethacin—PLA2G2A—telencephalon—epilepsy syndrome	0.000423	0.0178	CbGeAlD
Indomethacin—PTGR2—central nervous system—epilepsy syndrome	0.000418	0.0176	CbGeAlD
Indomethacin—Naproxen—SLCO1A2—epilepsy syndrome	0.000418	0.482	CrCbGaD
Indomethacin—PTGR2—cerebellum—epilepsy syndrome	0.000409	0.0172	CbGeAlD
Indomethacin—GLO1—medulla oblongata—epilepsy syndrome	0.000357	0.015	CbGeAlD
Indomethacin—PTGR2—brain—epilepsy syndrome	0.000332	0.014	CbGeAlD
Indomethacin—CXCL8—medulla oblongata—epilepsy syndrome	0.000329	0.0138	CbGeAlD
Indomethacin—GLO1—midbrain—epilepsy syndrome	0.000327	0.0138	CbGeAlD
Indomethacin—GLO1—spinal cord—epilepsy syndrome	0.000319	0.0134	CbGeAlD
Indomethacin—PLA2G2A—midbrain—epilepsy syndrome	0.000304	0.0128	CbGeAlD
Indomethacin—PTGS1—ganglion—epilepsy syndrome	0.000301	0.0127	CbGeAlD
Indomethacin—CXCL8—midbrain—epilepsy syndrome	0.000301	0.0127	CbGeAlD
Indomethacin—CXCL8—spinal cord—epilepsy syndrome	0.000293	0.0123	CbGeAlD
Indomethacin—GLO1—head—epilepsy syndrome	0.000283	0.0119	CbGeAlD
Indomethacin—GLO1—nervous system—epilepsy syndrome	0.000269	0.0113	CbGeAlD
Indomethacin—PLA2G2A—head—epilepsy syndrome	0.000263	0.0111	CbGeAlD
Indomethacin—ABCC6—head—epilepsy syndrome	0.000261	0.011	CbGeAlD
Indomethacin—GLO1—central nervous system—epilepsy syndrome	0.000259	0.0109	CbGeAlD
Indomethacin—AKR1C3—medulla oblongata—epilepsy syndrome	0.000258	0.0109	CbGeAlD
Indomethacin—GLO1—cerebellum—epilepsy syndrome	0.000253	0.0106	CbGeAlD
Indomethacin—PLA2G2A—nervous system—epilepsy syndrome	0.00025	0.0105	CbGeAlD
Indomethacin—PPARA—head—epilepsy syndrome	0.000246	0.0104	CbGeAlD
Indomethacin—PLA2G2A—central nervous system—epilepsy syndrome	0.00024	0.0101	CbGeAlD
Indomethacin—SLC10A1—head—epilepsy syndrome	0.000237	0.00996	CbGeAlD
Indomethacin—PPARG—forebrain—epilepsy syndrome	0.000236	0.00994	CbGeAlD
Indomethacin—AKR1C3—midbrain—epilepsy syndrome	0.000236	0.00992	CbGeAlD
Indomethacin—PPARA—nervous system—epilepsy syndrome	0.000233	0.00982	CbGeAlD
Indomethacin—CXCL8—cerebellum—epilepsy syndrome	0.000233	0.00979	CbGeAlD
Indomethacin—AKR1C3—spinal cord—epilepsy syndrome	0.00023	0.00968	CbGeAlD
Indomethacin—PPARA—central nervous system—epilepsy syndrome	0.000224	0.00945	CbGeAlD
Indomethacin—SLC10A1—nervous system—epilepsy syndrome	0.000224	0.00944	CbGeAlD
Indomethacin—SLCO1A2—forebrain—epilepsy syndrome	0.000223	0.00938	CbGeAlD
Indomethacin—PPARA—cerebellum—epilepsy syndrome	0.000219	0.00924	CbGeAlD
Indomethacin—SLC10A1—central nervous system—epilepsy syndrome	0.000216	0.00909	CbGeAlD
Indomethacin—ABCC4—forebrain—epilepsy syndrome	0.000214	0.00903	CbGeAlD
Indomethacin—GLO1—brain—epilepsy syndrome	0.000205	0.00864	CbGeAlD
Indomethacin—SLCO1A2—telencephalon—epilepsy syndrome	0.000205	0.00863	CbGeAlD
Indomethacin—PLA2G2A—brain—epilepsy syndrome	0.000191	0.00803	CbGeAlD
Indomethacin—CXCL8—brain—epilepsy syndrome	0.000189	0.00795	CbGeAlD
Indomethacin—CES1—head—epilepsy syndrome	0.000183	0.00768	CbGeAlD
Indomethacin—AKR1C3—cerebellum—epilepsy syndrome	0.000182	0.00767	CbGeAlD
Indomethacin—PPARA—brain—epilepsy syndrome	0.000178	0.0075	CbGeAlD
Indomethacin—CES1—nervous system—epilepsy syndrome	0.000173	0.00728	CbGeAlD
Indomethacin—SLC10A1—brain—epilepsy syndrome	0.000171	0.00722	CbGeAlD
Indomethacin—Bromfenac—PTGS2—epilepsy syndrome	0.000171	0.197	CrCbGaD
Indomethacin—ABCC1—telencephalon—epilepsy syndrome	0.000168	0.00708	CbGeAlD
Indomethacin—CES1—central nervous system—epilepsy syndrome	0.000167	0.00701	CbGeAlD
Indomethacin—SLCO1A2—medulla oblongata—epilepsy syndrome	0.000161	0.00678	CbGeAlD
Indomethacin—SLC22A7—brain—epilepsy syndrome	0.000153	0.00643	CbGeAlD
Indomethacin—ABCC3—head—epilepsy syndrome	0.000149	0.00626	CbGeAlD
Indomethacin—AKR1C3—brain—epilepsy syndrome	0.000148	0.00623	CbGeAlD
Indomethacin—SLC22A6—brain—epilepsy syndrome	0.000147	0.00621	CbGeAlD
Indomethacin—SLCO1A2—midbrain—epilepsy syndrome	0.000147	0.0062	CbGeAlD
Indomethacin—SLCO1A2—spinal cord—epilepsy syndrome	0.000144	0.00604	CbGeAlD
Indomethacin—ABCC3—nervous system—epilepsy syndrome	0.000141	0.00594	CbGeAlD
Indomethacin—ABCC3—central nervous system—epilepsy syndrome	0.000136	0.00572	CbGeAlD
Indomethacin—PPARG—head—epilepsy syndrome	0.000135	0.00569	CbGeAlD
Indomethacin—CES1—brain—epilepsy syndrome	0.000132	0.00557	CbGeAlD
Indomethacin—PPARG—nervous system—epilepsy syndrome	0.000128	0.0054	CbGeAlD
Indomethacin—SLCO1A2—head—epilepsy syndrome	0.000128	0.00537	CbGeAlD
Indomethacin—PTGS1—forebrain—epilepsy syndrome	0.000126	0.00532	CbGeAlD
Indomethacin—PPARG—central nervous system—epilepsy syndrome	0.000123	0.0052	CbGeAlD
Indomethacin—ABCC4—head—epilepsy syndrome	0.000123	0.00517	CbGeAlD
Indomethacin—SLC22A8—head—epilepsy syndrome	0.000122	0.00513	CbGeAlD
Indomethacin—SLCO1A2—nervous system—epilepsy syndrome	0.000121	0.00509	CbGeAlD
Indomethacin—PTGS2—forebrain—epilepsy syndrome	0.000121	0.00508	CbGeAlD
Indomethacin—SLCO1A2—central nervous system—epilepsy syndrome	0.000116	0.0049	CbGeAlD
Indomethacin—ABCC4—nervous system—epilepsy syndrome	0.000116	0.0049	CbGeAlD
Indomethacin—PTGS1—telencephalon—epilepsy syndrome	0.000116	0.00489	CbGeAlD
Indomethacin—SLC22A8—nervous system—epilepsy syndrome	0.000116	0.00486	CbGeAlD
Indomethacin—Tolmetin—PTGS2—epilepsy syndrome	0.000115	0.133	CrCbGaD
Indomethacin—SLCO1A2—cerebellum—epilepsy syndrome	0.000114	0.00479	CbGeAlD
Indomethacin—ABCC4—central nervous system—epilepsy syndrome	0.000112	0.00472	CbGeAlD
Indomethacin—SLC22A8—central nervous system—epilepsy syndrome	0.000111	0.00468	CbGeAlD
Indomethacin—PTGS2—telencephalon—epilepsy syndrome	0.000111	0.00467	CbGeAlD
Indomethacin—ABCC3—brain—epilepsy syndrome	0.000108	0.00454	CbGeAlD
Indomethacin—PPARG—brain—epilepsy syndrome	9.8e-05	0.00413	CbGeAlD
Indomethacin—ABCC1—cerebellum—epilepsy syndrome	9.34e-05	0.00393	CbGeAlD
Indomethacin—SLCO1A2—brain—epilepsy syndrome	9.25e-05	0.00389	CbGeAlD
Indomethacin—ALB—brain—epilepsy syndrome	9.19e-05	0.00387	CbGeAlD
Indomethacin—ABCC4—brain—epilepsy syndrome	8.9e-05	0.00375	CbGeAlD
Indomethacin—SLC22A8—brain—epilepsy syndrome	8.83e-05	0.00372	CbGeAlD
Indomethacin—PTGS2—medulla oblongata—epilepsy syndrome	8.72e-05	0.00367	CbGeAlD
Indomethacin—Naproxen—PTGS2—epilepsy syndrome	8.64e-05	0.0997	CrCbGaD
Indomethacin—PTGS1—spinal cord—epilepsy syndrome	8.14e-05	0.00342	CbGeAlD
Indomethacin—PTGS2—midbrain—epilepsy syndrome	7.97e-05	0.00336	CbGeAlD
Indomethacin—PTGS2—spinal cord—epilepsy syndrome	7.78e-05	0.00327	CbGeAlD
Indomethacin—Naproxen—ALB—epilepsy syndrome	7.7e-05	0.0888	CrCbGaD
Indomethacin—ABCC1—brain—epilepsy syndrome	7.59e-05	0.00319	CbGeAlD
Indomethacin—ABCB1—forebrain—epilepsy syndrome	7.47e-05	0.00314	CbGeAlD
Indomethacin—PTGS1—head—epilepsy syndrome	7.23e-05	0.00304	CbGeAlD
Indomethacin—PTGS2—head—epilepsy syndrome	6.91e-05	0.00291	CbGeAlD
Indomethacin—ABCB1—telencephalon—epilepsy syndrome	6.86e-05	0.00289	CbGeAlD
Indomethacin—PTGS1—nervous system—epilepsy syndrome	6.85e-05	0.00289	CbGeAlD
Indomethacin—PTGS1—central nervous system—epilepsy syndrome	6.6e-05	0.00278	CbGeAlD
Indomethacin—PTGS2—nervous system—epilepsy syndrome	6.55e-05	0.00276	CbGeAlD
Indomethacin—PTGS2—central nervous system—epilepsy syndrome	6.31e-05	0.00266	CbGeAlD
Indomethacin—PTGS2—cerebellum—epilepsy syndrome	6.17e-05	0.0026	CbGeAlD
Indomethacin—ABCB1—medulla oblongata—epilepsy syndrome	5.39e-05	0.00227	CbGeAlD
Indomethacin—PTGS1—brain—epilepsy syndrome	5.24e-05	0.00221	CbGeAlD
Indomethacin—PTGS2—brain—epilepsy syndrome	5.01e-05	0.00211	CbGeAlD
Indomethacin—ABCB1—midbrain—epilepsy syndrome	4.93e-05	0.00208	CbGeAlD
Indomethacin—ABCB1—spinal cord—epilepsy syndrome	4.81e-05	0.00202	CbGeAlD
Indomethacin—ABCB1—head—epilepsy syndrome	4.27e-05	0.0018	CbGeAlD
Indomethacin—ABCB1—nervous system—epilepsy syndrome	4.05e-05	0.00171	CbGeAlD
Indomethacin—ABCB1—central nervous system—epilepsy syndrome	3.9e-05	0.00164	CbGeAlD
Indomethacin—ABCB1—cerebellum—epilepsy syndrome	3.81e-05	0.00161	CbGeAlD
Indomethacin—ABCB1—brain—epilepsy syndrome	3.1e-05	0.0013	CbGeAlD
Indomethacin—Rash—Fosphenytoin—epilepsy syndrome	2.71e-05	0.000245	CcSEcCtD
Indomethacin—Dermatitis—Fosphenytoin—epilepsy syndrome	2.71e-05	0.000245	CcSEcCtD
Indomethacin—Haemoglobin—Topiramate—epilepsy syndrome	2.71e-05	0.000245	CcSEcCtD
Indomethacin—Nervousness—Gabapentin—epilepsy syndrome	2.71e-05	0.000245	CcSEcCtD
Indomethacin—Asthenia—Clonazepam—epilepsy syndrome	2.7e-05	0.000245	CcSEcCtD
Indomethacin—Headache—Fosphenytoin—epilepsy syndrome	2.69e-05	0.000244	CcSEcCtD
Indomethacin—Haemorrhage—Topiramate—epilepsy syndrome	2.69e-05	0.000244	CcSEcCtD
Indomethacin—Hepatitis—Topiramate—epilepsy syndrome	2.69e-05	0.000244	CcSEcCtD
Indomethacin—Thrombocytopenia—Valproic Acid—epilepsy syndrome	2.69e-05	0.000243	CcSEcCtD
Indomethacin—Palpitations—Pregabalin—epilepsy syndrome	2.69e-05	0.000243	CcSEcCtD
Indomethacin—Asthenia—Phenytoin—epilepsy syndrome	2.69e-05	0.000243	CcSEcCtD
Indomethacin—Nausea—Midazolam—epilepsy syndrome	2.68e-05	0.000243	CcSEcCtD
Indomethacin—Tachycardia—Valproic Acid—epilepsy syndrome	2.68e-05	0.000242	CcSEcCtD
Indomethacin—Diarrhoea—Zonisamide—epilepsy syndrome	2.68e-05	0.000242	CcSEcCtD
Indomethacin—Loss of consciousness—Pregabalin—epilepsy syndrome	2.67e-05	0.000242	CcSEcCtD
Indomethacin—Asthenia—Oxcarbazepine—epilepsy syndrome	2.67e-05	0.000242	CcSEcCtD
Indomethacin—Pruritus—Clonazepam—epilepsy syndrome	2.67e-05	0.000241	CcSEcCtD
Indomethacin—Vomiting—Vigabatrin—epilepsy syndrome	2.67e-05	0.000241	CcSEcCtD
Indomethacin—Hyperhidrosis—Valproic Acid—epilepsy syndrome	2.65e-05	0.00024	CcSEcCtD
Indomethacin—Pruritus—Phenytoin—epilepsy syndrome	2.65e-05	0.00024	CcSEcCtD
Indomethacin—Nausea—Levetiracetam—epilepsy syndrome	2.65e-05	0.000239	CcSEcCtD
Indomethacin—Rash—Vigabatrin—epilepsy syndrome	2.64e-05	0.000239	CcSEcCtD
Indomethacin—Dizziness—Felbamate—epilepsy syndrome	2.64e-05	0.000239	CcSEcCtD
Indomethacin—Dermatitis—Vigabatrin—epilepsy syndrome	2.64e-05	0.000239	CcSEcCtD
Indomethacin—Pruritus—Oxcarbazepine—epilepsy syndrome	2.63e-05	0.000238	CcSEcCtD
Indomethacin—Convulsion—Pregabalin—epilepsy syndrome	2.63e-05	0.000238	CcSEcCtD
Indomethacin—Hypersensitivity—Carbamazepine—epilepsy syndrome	2.63e-05	0.000238	CcSEcCtD
Indomethacin—Vision blurred—Gabapentin—epilepsy syndrome	2.63e-05	0.000238	CcSEcCtD
Indomethacin—Headache—Vigabatrin—epilepsy syndrome	2.63e-05	0.000238	CcSEcCtD
Indomethacin—Hypertension—Pregabalin—epilepsy syndrome	2.62e-05	0.000237	CcSEcCtD
Indomethacin—Vomiting—Diazepam—epilepsy syndrome	2.62e-05	0.000237	CcSEcCtD
Indomethacin—Anorexia—Valproic Acid—epilepsy syndrome	2.62e-05	0.000237	CcSEcCtD
Indomethacin—Rash—Diazepam—epilepsy syndrome	2.6e-05	0.000235	CcSEcCtD
Indomethacin—Dermatitis—Diazepam—epilepsy syndrome	2.6e-05	0.000235	CcSEcCtD
Indomethacin—Chest pain—Pregabalin—epilepsy syndrome	2.59e-05	0.000234	CcSEcCtD
Indomethacin—Ill-defined disorder—Gabapentin—epilepsy syndrome	2.59e-05	0.000234	CcSEcCtD
Indomethacin—Dizziness—Zonisamide—epilepsy syndrome	2.59e-05	0.000234	CcSEcCtD
Indomethacin—Headache—Diazepam—epilepsy syndrome	2.59e-05	0.000234	CcSEcCtD
Indomethacin—Anxiety—Pregabalin—epilepsy syndrome	2.58e-05	0.000233	CcSEcCtD
Indomethacin—Diarrhoea—Clonazepam—epilepsy syndrome	2.58e-05	0.000233	CcSEcCtD
Indomethacin—Anaemia—Gabapentin—epilepsy syndrome	2.58e-05	0.000233	CcSEcCtD
Indomethacin—Hypotension—Valproic Acid—epilepsy syndrome	2.56e-05	0.000232	CcSEcCtD
Indomethacin—Asthenia—Carbamazepine—epilepsy syndrome	2.56e-05	0.000232	CcSEcCtD
Indomethacin—Diarrhoea—Phenytoin—epilepsy syndrome	2.56e-05	0.000232	CcSEcCtD
Indomethacin—Discomfort—Pregabalin—epilepsy syndrome	2.56e-05	0.000231	CcSEcCtD
Indomethacin—Nausea—Fosphenytoin—epilepsy syndrome	2.55e-05	0.000231	CcSEcCtD
Indomethacin—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.55e-05	0.000231	CcSEcCtD
Indomethacin—Erythema multiforme—Topiramate—epilepsy syndrome	2.55e-05	0.00023	CcSEcCtD
Indomethacin—Angioedema—Gabapentin—epilepsy syndrome	2.55e-05	0.00023	CcSEcCtD
Indomethacin—Hypersensitivity—Lamotrigine—epilepsy syndrome	2.54e-05	0.00023	CcSEcCtD
Indomethacin—Vomiting—Felbamate—epilepsy syndrome	2.54e-05	0.00023	CcSEcCtD
Indomethacin—Pruritus—Carbamazepine—epilepsy syndrome	2.53e-05	0.000229	CcSEcCtD
Indomethacin—Rash—Felbamate—epilepsy syndrome	2.52e-05	0.000228	CcSEcCtD
Indomethacin—Dermatitis—Felbamate—epilepsy syndrome	2.52e-05	0.000228	CcSEcCtD
Indomethacin—Malaise—Gabapentin—epilepsy syndrome	2.51e-05	0.000227	CcSEcCtD
Indomethacin—Tinnitus—Topiramate—epilepsy syndrome	2.51e-05	0.000227	CcSEcCtD
Indomethacin—Vertigo—Gabapentin—epilepsy syndrome	2.5e-05	0.000227	CcSEcCtD
Indomethacin—Headache—Felbamate—epilepsy syndrome	2.5e-05	0.000226	CcSEcCtD
Indomethacin—Confusional state—Pregabalin—epilepsy syndrome	2.5e-05	0.000226	CcSEcCtD
Indomethacin—Flushing—Topiramate—epilepsy syndrome	2.5e-05	0.000226	CcSEcCtD
Indomethacin—Syncope—Gabapentin—epilepsy syndrome	2.5e-05	0.000226	CcSEcCtD
Indomethacin—Leukopenia—Gabapentin—epilepsy syndrome	2.5e-05	0.000226	CcSEcCtD
Indomethacin—Dizziness—Clonazepam—epilepsy syndrome	2.49e-05	0.000225	CcSEcCtD
Indomethacin—Nausea—Vigabatrin—epilepsy syndrome	2.49e-05	0.000225	CcSEcCtD
Indomethacin—Vomiting—Zonisamide—epilepsy syndrome	2.49e-05	0.000225	CcSEcCtD
Indomethacin—Insomnia—Valproic Acid—epilepsy syndrome	2.48e-05	0.000225	CcSEcCtD
Indomethacin—Oedema—Pregabalin—epilepsy syndrome	2.48e-05	0.000224	CcSEcCtD
Indomethacin—Anaphylactic shock—Pregabalin—epilepsy syndrome	2.48e-05	0.000224	CcSEcCtD
Indomethacin—Asthenia—Lamotrigine—epilepsy syndrome	2.48e-05	0.000224	CcSEcCtD
Indomethacin—Dizziness—Phenytoin—epilepsy syndrome	2.48e-05	0.000224	CcSEcCtD
Indomethacin—Rash—Zonisamide—epilepsy syndrome	2.47e-05	0.000223	CcSEcCtD
Indomethacin—Paraesthesia—Valproic Acid—epilepsy syndrome	2.46e-05	0.000223	CcSEcCtD
Indomethacin—Palpitations—Gabapentin—epilepsy syndrome	2.46e-05	0.000223	CcSEcCtD
Indomethacin—Dermatitis—Zonisamide—epilepsy syndrome	2.46e-05	0.000223	CcSEcCtD
Indomethacin—Dizziness—Oxcarbazepine—epilepsy syndrome	2.46e-05	0.000223	CcSEcCtD
Indomethacin—Nausea—Diazepam—epilepsy syndrome	2.45e-05	0.000222	CcSEcCtD
Indomethacin—Loss of consciousness—Gabapentin—epilepsy syndrome	2.45e-05	0.000222	CcSEcCtD
Indomethacin—Headache—Zonisamide—epilepsy syndrome	2.45e-05	0.000222	CcSEcCtD
Indomethacin—Dyspnoea—Valproic Acid—epilepsy syndrome	2.45e-05	0.000221	CcSEcCtD
Indomethacin—Diarrhoea—Carbamazepine—epilepsy syndrome	2.44e-05	0.000221	CcSEcCtD
Indomethacin—Pruritus—Lamotrigine—epilepsy syndrome	2.44e-05	0.000221	CcSEcCtD
Indomethacin—Shock—Pregabalin—epilepsy syndrome	2.44e-05	0.000221	CcSEcCtD
Indomethacin—Somnolence—Valproic Acid—epilepsy syndrome	2.44e-05	0.000221	CcSEcCtD
Indomethacin—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.43e-05	0.00022	CcSEcCtD
Indomethacin—Tachycardia—Pregabalin—epilepsy syndrome	2.42e-05	0.000219	CcSEcCtD
Indomethacin—Dyspepsia—Valproic Acid—epilepsy syndrome	2.42e-05	0.000219	CcSEcCtD
Indomethacin—Convulsion—Gabapentin—epilepsy syndrome	2.42e-05	0.000219	CcSEcCtD
Indomethacin—Hypertension—Gabapentin—epilepsy syndrome	2.41e-05	0.000218	CcSEcCtD
Indomethacin—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.4e-05	0.000217	CcSEcCtD
Indomethacin—Vomiting—Clonazepam—epilepsy syndrome	2.4e-05	0.000217	CcSEcCtD
Indomethacin—Decreased appetite—Valproic Acid—epilepsy syndrome	2.39e-05	0.000216	CcSEcCtD
Indomethacin—Alopecia—Topiramate—epilepsy syndrome	2.38e-05	0.000215	CcSEcCtD
Indomethacin—Vomiting—Phenytoin—epilepsy syndrome	2.38e-05	0.000215	CcSEcCtD
Indomethacin—Rash—Clonazepam—epilepsy syndrome	2.38e-05	0.000215	CcSEcCtD
Indomethacin—Dermatitis—Clonazepam—epilepsy syndrome	2.37e-05	0.000215	CcSEcCtD
Indomethacin—Chest pain—Gabapentin—epilepsy syndrome	2.37e-05	0.000215	CcSEcCtD
Indomethacin—Nausea—Felbamate—epilepsy syndrome	2.37e-05	0.000215	CcSEcCtD
Indomethacin—Vomiting—Oxcarbazepine—epilepsy syndrome	2.37e-05	0.000214	CcSEcCtD
Indomethacin—Fatigue—Valproic Acid—epilepsy syndrome	2.37e-05	0.000214	CcSEcCtD
Indomethacin—Anxiety—Gabapentin—epilepsy syndrome	2.36e-05	0.000214	CcSEcCtD
Indomethacin—Anorexia—Pregabalin—epilepsy syndrome	2.36e-05	0.000214	CcSEcCtD
Indomethacin—Dizziness—Carbamazepine—epilepsy syndrome	2.36e-05	0.000214	CcSEcCtD
Indomethacin—Diarrhoea—Lamotrigine—epilepsy syndrome	2.36e-05	0.000214	CcSEcCtD
Indomethacin—Headache—Clonazepam—epilepsy syndrome	2.36e-05	0.000214	CcSEcCtD
Indomethacin—Rash—Phenytoin—epilepsy syndrome	2.36e-05	0.000214	CcSEcCtD
Indomethacin—Dermatitis—Phenytoin—epilepsy syndrome	2.36e-05	0.000213	CcSEcCtD
Indomethacin—Rash—Oxcarbazepine—epilepsy syndrome	2.35e-05	0.000212	CcSEcCtD
Indomethacin—Constipation—Valproic Acid—epilepsy syndrome	2.35e-05	0.000212	CcSEcCtD
Indomethacin—Pain—Valproic Acid—epilepsy syndrome	2.35e-05	0.000212	CcSEcCtD
Indomethacin—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.35e-05	0.000212	CcSEcCtD
Indomethacin—Headache—Phenytoin—epilepsy syndrome	2.35e-05	0.000212	CcSEcCtD
Indomethacin—Erythema—Topiramate—epilepsy syndrome	2.35e-05	0.000212	CcSEcCtD
Indomethacin—Discomfort—Gabapentin—epilepsy syndrome	2.34e-05	0.000212	CcSEcCtD
Indomethacin—Headache—Oxcarbazepine—epilepsy syndrome	2.33e-05	0.000211	CcSEcCtD
Indomethacin—Nausea—Zonisamide—epilepsy syndrome	2.32e-05	0.00021	CcSEcCtD
Indomethacin—Hypotension—Pregabalin—epilepsy syndrome	2.32e-05	0.00021	CcSEcCtD
Indomethacin—Flatulence—Topiramate—epilepsy syndrome	2.31e-05	0.000209	CcSEcCtD
Indomethacin—Tension—Topiramate—epilepsy syndrome	2.3e-05	0.000208	CcSEcCtD
Indomethacin—Confusional state—Gabapentin—epilepsy syndrome	2.29e-05	0.000208	CcSEcCtD
Indomethacin—Dizziness—Lamotrigine—epilepsy syndrome	2.28e-05	0.000207	CcSEcCtD
Indomethacin—Nervousness—Topiramate—epilepsy syndrome	2.28e-05	0.000206	CcSEcCtD
Indomethacin—Oedema—Gabapentin—epilepsy syndrome	2.27e-05	0.000206	CcSEcCtD
Indomethacin—Anaphylactic shock—Gabapentin—epilepsy syndrome	2.27e-05	0.000206	CcSEcCtD
Indomethacin—Vomiting—Carbamazepine—epilepsy syndrome	2.27e-05	0.000206	CcSEcCtD
Indomethacin—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.26e-05	0.000205	CcSEcCtD
Indomethacin—Rash—Carbamazepine—epilepsy syndrome	2.25e-05	0.000204	CcSEcCtD
Indomethacin—Dermatitis—Carbamazepine—epilepsy syndrome	2.25e-05	0.000204	CcSEcCtD
Indomethacin—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.24e-05	0.000203	CcSEcCtD
Indomethacin—Insomnia—Pregabalin—epilepsy syndrome	2.24e-05	0.000203	CcSEcCtD
Indomethacin—Nausea—Clonazepam—epilepsy syndrome	2.24e-05	0.000203	CcSEcCtD
Indomethacin—Headache—Carbamazepine—epilepsy syndrome	2.24e-05	0.000203	CcSEcCtD
Indomethacin—Shock—Gabapentin—epilepsy syndrome	2.24e-05	0.000202	CcSEcCtD
Indomethacin—Paraesthesia—Pregabalin—epilepsy syndrome	2.23e-05	0.000202	CcSEcCtD
Indomethacin—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.23e-05	0.000202	CcSEcCtD
Indomethacin—Nausea—Phenytoin—epilepsy syndrome	2.22e-05	0.000201	CcSEcCtD
Indomethacin—Tachycardia—Gabapentin—epilepsy syndrome	2.22e-05	0.000201	CcSEcCtD
Indomethacin—Dyspnoea—Pregabalin—epilepsy syndrome	2.21e-05	0.0002	CcSEcCtD
Indomethacin—Nausea—Oxcarbazepine—epilepsy syndrome	2.21e-05	0.0002	CcSEcCtD
Indomethacin—Vision blurred—Topiramate—epilepsy syndrome	2.21e-05	0.0002	CcSEcCtD
Indomethacin—Somnolence—Pregabalin—epilepsy syndrome	2.21e-05	0.0002	CcSEcCtD
Indomethacin—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.2e-05	0.000199	CcSEcCtD
Indomethacin—Vomiting—Lamotrigine—epilepsy syndrome	2.2e-05	0.000199	CcSEcCtD
Indomethacin—Urticaria—Valproic Acid—epilepsy syndrome	2.18e-05	0.000197	CcSEcCtD
Indomethacin—Rash—Lamotrigine—epilepsy syndrome	2.18e-05	0.000197	CcSEcCtD
Indomethacin—Ill-defined disorder—Topiramate—epilepsy syndrome	2.18e-05	0.000197	CcSEcCtD
Indomethacin—Dermatitis—Lamotrigine—epilepsy syndrome	2.18e-05	0.000197	CcSEcCtD
Indomethacin—Abdominal pain—Valproic Acid—epilepsy syndrome	2.17e-05	0.000196	CcSEcCtD
Indomethacin—Body temperature increased—Valproic Acid—epilepsy syndrome	2.17e-05	0.000196	CcSEcCtD
Indomethacin—Anorexia—Gabapentin—epilepsy syndrome	2.17e-05	0.000196	CcSEcCtD
Indomethacin—Anaemia—Topiramate—epilepsy syndrome	2.17e-05	0.000196	CcSEcCtD
Indomethacin—Headache—Lamotrigine—epilepsy syndrome	2.16e-05	0.000196	CcSEcCtD
Indomethacin—Decreased appetite—Pregabalin—epilepsy syndrome	2.16e-05	0.000195	CcSEcCtD
Indomethacin—Fatigue—Pregabalin—epilepsy syndrome	2.14e-05	0.000194	CcSEcCtD
Indomethacin—Hypotension—Gabapentin—epilepsy syndrome	2.13e-05	0.000192	CcSEcCtD
Indomethacin—Nausea—Carbamazepine—epilepsy syndrome	2.12e-05	0.000192	CcSEcCtD
Indomethacin—Pain—Pregabalin—epilepsy syndrome	2.12e-05	0.000192	CcSEcCtD
Indomethacin—Constipation—Pregabalin—epilepsy syndrome	2.12e-05	0.000192	CcSEcCtD
Indomethacin—Malaise—Topiramate—epilepsy syndrome	2.11e-05	0.000191	CcSEcCtD
Indomethacin—Vertigo—Topiramate—epilepsy syndrome	2.11e-05	0.000191	CcSEcCtD
Indomethacin—Syncope—Topiramate—epilepsy syndrome	2.1e-05	0.00019	CcSEcCtD
Indomethacin—Leukopenia—Topiramate—epilepsy syndrome	2.1e-05	0.00019	CcSEcCtD
Indomethacin—Palpitations—Topiramate—epilepsy syndrome	2.07e-05	0.000187	CcSEcCtD
Indomethacin—Loss of consciousness—Topiramate—epilepsy syndrome	2.06e-05	0.000186	CcSEcCtD
Indomethacin—Insomnia—Gabapentin—epilepsy syndrome	2.06e-05	0.000186	CcSEcCtD
Indomethacin—Nausea—Lamotrigine—epilepsy syndrome	2.05e-05	0.000186	CcSEcCtD
Indomethacin—Feeling abnormal—Pregabalin—epilepsy syndrome	2.04e-05	0.000185	CcSEcCtD
Indomethacin—Paraesthesia—Gabapentin—epilepsy syndrome	2.04e-05	0.000185	CcSEcCtD
Indomethacin—Convulsion—Topiramate—epilepsy syndrome	2.03e-05	0.000184	CcSEcCtD
Indomethacin—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.03e-05	0.000184	CcSEcCtD
Indomethacin—Dyspnoea—Gabapentin—epilepsy syndrome	2.03e-05	0.000183	CcSEcCtD
Indomethacin—Hypertension—Topiramate—epilepsy syndrome	2.02e-05	0.000183	CcSEcCtD
Indomethacin—Somnolence—Gabapentin—epilepsy syndrome	2.02e-05	0.000183	CcSEcCtD
Indomethacin—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.02e-05	0.000183	CcSEcCtD
Indomethacin—Dyspepsia—Gabapentin—epilepsy syndrome	2e-05	0.000181	CcSEcCtD
Indomethacin—Chest pain—Topiramate—epilepsy syndrome	2e-05	0.000181	CcSEcCtD
Indomethacin—Anxiety—Topiramate—epilepsy syndrome	1.99e-05	0.00018	CcSEcCtD
Indomethacin—Decreased appetite—Gabapentin—epilepsy syndrome	1.98e-05	0.000179	CcSEcCtD
Indomethacin—Discomfort—Topiramate—epilepsy syndrome	1.97e-05	0.000178	CcSEcCtD
Indomethacin—Urticaria—Pregabalin—epilepsy syndrome	1.97e-05	0.000178	CcSEcCtD
Indomethacin—Asthenia—Valproic Acid—epilepsy syndrome	1.97e-05	0.000178	CcSEcCtD
Indomethacin—Fatigue—Gabapentin—epilepsy syndrome	1.96e-05	0.000177	CcSEcCtD
Indomethacin—Abdominal pain—Pregabalin—epilepsy syndrome	1.96e-05	0.000177	CcSEcCtD
Indomethacin—Body temperature increased—Pregabalin—epilepsy syndrome	1.96e-05	0.000177	CcSEcCtD
Indomethacin—Pain—Gabapentin—epilepsy syndrome	1.95e-05	0.000176	CcSEcCtD
Indomethacin—Constipation—Gabapentin—epilepsy syndrome	1.95e-05	0.000176	CcSEcCtD
Indomethacin—Pruritus—Valproic Acid—epilepsy syndrome	1.94e-05	0.000176	CcSEcCtD
Indomethacin—Confusional state—Topiramate—epilepsy syndrome	1.93e-05	0.000175	CcSEcCtD
Indomethacin—Oedema—Topiramate—epilepsy syndrome	1.91e-05	0.000173	CcSEcCtD
Indomethacin—Shock—Topiramate—epilepsy syndrome	1.88e-05	0.00017	CcSEcCtD
Indomethacin—Diarrhoea—Valproic Acid—epilepsy syndrome	1.88e-05	0.00017	CcSEcCtD
Indomethacin—Feeling abnormal—Gabapentin—epilepsy syndrome	1.87e-05	0.00017	CcSEcCtD
Indomethacin—Thrombocytopenia—Topiramate—epilepsy syndrome	1.87e-05	0.00017	CcSEcCtD
Indomethacin—Tachycardia—Topiramate—epilepsy syndrome	1.87e-05	0.000169	CcSEcCtD
Indomethacin—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.86e-05	0.000168	CcSEcCtD
Indomethacin—Hyperhidrosis—Topiramate—epilepsy syndrome	1.85e-05	0.000167	CcSEcCtD
Indomethacin—Hypersensitivity—Pregabalin—epilepsy syndrome	1.83e-05	0.000165	CcSEcCtD
Indomethacin—Anorexia—Topiramate—epilepsy syndrome	1.82e-05	0.000165	CcSEcCtD
Indomethacin—Dizziness—Valproic Acid—epilepsy syndrome	1.81e-05	0.000164	CcSEcCtD
Indomethacin—Urticaria—Gabapentin—epilepsy syndrome	1.81e-05	0.000164	CcSEcCtD
Indomethacin—Abdominal pain—Gabapentin—epilepsy syndrome	1.8e-05	0.000163	CcSEcCtD
Indomethacin—Body temperature increased—Gabapentin—epilepsy syndrome	1.8e-05	0.000163	CcSEcCtD
Indomethacin—Hypotension—Topiramate—epilepsy syndrome	1.79e-05	0.000162	CcSEcCtD
Indomethacin—Asthenia—Pregabalin—epilepsy syndrome	1.78e-05	0.000161	CcSEcCtD
Indomethacin—Pruritus—Pregabalin—epilepsy syndrome	1.76e-05	0.000159	CcSEcCtD
Indomethacin—Vomiting—Valproic Acid—epilepsy syndrome	1.74e-05	0.000158	CcSEcCtD
Indomethacin—Insomnia—Topiramate—epilepsy syndrome	1.73e-05	0.000157	CcSEcCtD
Indomethacin—Rash—Valproic Acid—epilepsy syndrome	1.73e-05	0.000157	CcSEcCtD
Indomethacin—Dermatitis—Valproic Acid—epilepsy syndrome	1.73e-05	0.000156	CcSEcCtD
Indomethacin—Headache—Valproic Acid—epilepsy syndrome	1.72e-05	0.000156	CcSEcCtD
Indomethacin—Paraesthesia—Topiramate—epilepsy syndrome	1.72e-05	0.000155	CcSEcCtD
Indomethacin—Dyspnoea—Topiramate—epilepsy syndrome	1.71e-05	0.000154	CcSEcCtD
Indomethacin—Somnolence—Topiramate—epilepsy syndrome	1.7e-05	0.000154	CcSEcCtD
Indomethacin—Diarrhoea—Pregabalin—epilepsy syndrome	1.7e-05	0.000154	CcSEcCtD
Indomethacin—Dyspepsia—Topiramate—epilepsy syndrome	1.68e-05	0.000152	CcSEcCtD
Indomethacin—Hypersensitivity—Gabapentin—epilepsy syndrome	1.68e-05	0.000152	CcSEcCtD
Indomethacin—Decreased appetite—Topiramate—epilepsy syndrome	1.66e-05	0.000151	CcSEcCtD
Indomethacin—Fatigue—Topiramate—epilepsy syndrome	1.65e-05	0.000149	CcSEcCtD
Indomethacin—Dizziness—Pregabalin—epilepsy syndrome	1.64e-05	0.000148	CcSEcCtD
Indomethacin—Pain—Topiramate—epilepsy syndrome	1.64e-05	0.000148	CcSEcCtD
Indomethacin—Constipation—Topiramate—epilepsy syndrome	1.64e-05	0.000148	CcSEcCtD
Indomethacin—Asthenia—Gabapentin—epilepsy syndrome	1.63e-05	0.000148	CcSEcCtD
Indomethacin—Nausea—Valproic Acid—epilepsy syndrome	1.63e-05	0.000147	CcSEcCtD
Indomethacin—Pruritus—Gabapentin—epilepsy syndrome	1.61e-05	0.000146	CcSEcCtD
Indomethacin—Vomiting—Pregabalin—epilepsy syndrome	1.58e-05	0.000143	CcSEcCtD
Indomethacin—Feeling abnormal—Topiramate—epilepsy syndrome	1.58e-05	0.000143	CcSEcCtD
Indomethacin—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.57e-05	0.000142	CcSEcCtD
Indomethacin—Rash—Pregabalin—epilepsy syndrome	1.56e-05	0.000142	CcSEcCtD
Indomethacin—Dermatitis—Pregabalin—epilepsy syndrome	1.56e-05	0.000141	CcSEcCtD
Indomethacin—Diarrhoea—Gabapentin—epilepsy syndrome	1.56e-05	0.000141	CcSEcCtD
Indomethacin—Headache—Pregabalin—epilepsy syndrome	1.55e-05	0.000141	CcSEcCtD
Indomethacin—Urticaria—Topiramate—epilepsy syndrome	1.52e-05	0.000138	CcSEcCtD
Indomethacin—Body temperature increased—Topiramate—epilepsy syndrome	1.51e-05	0.000137	CcSEcCtD
Indomethacin—Abdominal pain—Topiramate—epilepsy syndrome	1.51e-05	0.000137	CcSEcCtD
Indomethacin—Dizziness—Gabapentin—epilepsy syndrome	1.5e-05	0.000136	CcSEcCtD
Indomethacin—Nausea—Pregabalin—epilepsy syndrome	1.47e-05	0.000133	CcSEcCtD
Indomethacin—Vomiting—Gabapentin—epilepsy syndrome	1.45e-05	0.000131	CcSEcCtD
Indomethacin—Rash—Gabapentin—epilepsy syndrome	1.43e-05	0.00013	CcSEcCtD
Indomethacin—Dermatitis—Gabapentin—epilepsy syndrome	1.43e-05	0.00013	CcSEcCtD
Indomethacin—Headache—Gabapentin—epilepsy syndrome	1.43e-05	0.000129	CcSEcCtD
Indomethacin—Hypersensitivity—Topiramate—epilepsy syndrome	1.41e-05	0.000128	CcSEcCtD
Indomethacin—Asthenia—Topiramate—epilepsy syndrome	1.37e-05	0.000124	CcSEcCtD
Indomethacin—Pruritus—Topiramate—epilepsy syndrome	1.35e-05	0.000123	CcSEcCtD
Indomethacin—Nausea—Gabapentin—epilepsy syndrome	1.35e-05	0.000122	CcSEcCtD
Indomethacin—Diarrhoea—Topiramate—epilepsy syndrome	1.31e-05	0.000118	CcSEcCtD
Indomethacin—Dizziness—Topiramate—epilepsy syndrome	1.27e-05	0.000115	CcSEcCtD
Indomethacin—Vomiting—Topiramate—epilepsy syndrome	1.22e-05	0.00011	CcSEcCtD
Indomethacin—Rash—Topiramate—epilepsy syndrome	1.21e-05	0.000109	CcSEcCtD
Indomethacin—Dermatitis—Topiramate—epilepsy syndrome	1.21e-05	0.000109	CcSEcCtD
Indomethacin—Headache—Topiramate—epilepsy syndrome	1.2e-05	0.000108	CcSEcCtD
Indomethacin—Nausea—Topiramate—epilepsy syndrome	1.14e-05	0.000103	CcSEcCtD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.55e-06	2.13e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SLC2A1—epilepsy syndrome	1.54e-06	2.13e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PRKCB—epilepsy syndrome	1.53e-06	2.11e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—JUNB—epilepsy syndrome	1.53e-06	2.11e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KDR—epilepsy syndrome	1.53e-06	2.1e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOS1—epilepsy syndrome	1.52e-06	2.1e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ABCB1—epilepsy syndrome	1.52e-06	2.1e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—NOS2—epilepsy syndrome	1.52e-06	2.09e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	1.51e-06	2.09e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.51e-06	2.08e-05	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.51e-06	2.08e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—HMOX1—epilepsy syndrome	1.51e-06	2.08e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—FGF2—epilepsy syndrome	1.5e-06	2.07e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AGT—epilepsy syndrome	1.5e-06	2.06e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CAT—epilepsy syndrome	1.49e-06	2.05e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TSC2—epilepsy syndrome	1.48e-06	2.04e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.48e-06	2.04e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AQP1—epilepsy syndrome	1.47e-06	2.02e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PRKCB—epilepsy syndrome	1.47e-06	2.02e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—GPX1—epilepsy syndrome	1.47e-06	2.02e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—GPX1—epilepsy syndrome	1.47e-06	2.02e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—APOE—epilepsy syndrome	1.47e-06	2.02e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL6ST—epilepsy syndrome	1.46e-06	2.01e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	1.46e-06	2.01e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	1.46e-06	2.01e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HBEGF—epilepsy syndrome	1.45e-06	2e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—APOE—epilepsy syndrome	1.45e-06	2e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ABCB1—epilepsy syndrome	1.45e-06	1.99e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	1.44e-06	1.98e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.43e-06	1.98e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CYP2D6—epilepsy syndrome	1.43e-06	1.97e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT3—epilepsy syndrome	1.43e-06	1.96e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	1.42e-06	1.96e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CHRM3—epilepsy syndrome	1.42e-06	1.96e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—GPX1—epilepsy syndrome	1.41e-06	1.95e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.41e-06	1.94e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PTGS2—epilepsy syndrome	1.4e-06	1.93e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ADAM10—epilepsy syndrome	1.39e-06	1.92e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—RELA—epilepsy syndrome	1.39e-06	1.92e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AGT—epilepsy syndrome	1.38e-06	1.9e-05	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—AKT1—epilepsy syndrome	1.38e-06	1.9e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MTOR—epilepsy syndrome	1.36e-06	1.88e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—IL6ST—epilepsy syndrome	1.36e-06	1.88e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ADRA2A—epilepsy syndrome	1.36e-06	1.88e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.36e-06	1.87e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—BCHE—epilepsy syndrome	1.36e-06	1.87e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NOS2—epilepsy syndrome	1.35e-06	1.86e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—APOE—epilepsy syndrome	1.35e-06	1.86e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—GPX1—epilepsy syndrome	1.34e-06	1.85e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—HMOX1—epilepsy syndrome	1.34e-06	1.85e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—POMC—epilepsy syndrome	1.34e-06	1.84e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—POMC—epilepsy syndrome	1.33e-06	1.84e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—POMC—epilepsy syndrome	1.33e-06	1.84e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.33e-06	1.83e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	1.33e-06	1.83e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	1.33e-06	1.83e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ABCG2—epilepsy syndrome	1.32e-06	1.82e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CAT—epilepsy syndrome	1.32e-06	1.82e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCL2—epilepsy syndrome	1.31e-06	1.8e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CDC42—epilepsy syndrome	1.3e-06	1.79e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—SLC2A1—epilepsy syndrome	1.29e-06	1.78e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP2C19—epilepsy syndrome	1.29e-06	1.78e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ABCB1—epilepsy syndrome	1.29e-06	1.77e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AGT—epilepsy syndrome	1.29e-06	1.77e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AGT—epilepsy syndrome	1.29e-06	1.77e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP11A1—epilepsy syndrome	1.28e-06	1.77e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PLCB1—epilepsy syndrome	1.28e-06	1.76e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—TH—epilepsy syndrome	1.27e-06	1.76e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.27e-06	1.75e-05	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—AKT1—epilepsy syndrome	1.27e-06	1.75e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—APOE—epilepsy syndrome	1.26e-06	1.74e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—APOE—epilepsy syndrome	1.26e-06	1.74e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—POMC—epilepsy syndrome	1.26e-06	1.74e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CASP3—epilepsy syndrome	1.26e-06	1.73e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AGT—epilepsy syndrome	1.24e-06	1.71e-05	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—AKT1—epilepsy syndrome	1.24e-06	1.71e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	1.24e-06	1.71e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—JUN—epilepsy syndrome	1.22e-06	1.68e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—APOE—epilepsy syndrome	1.22e-06	1.67e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—ALB—epilepsy syndrome	1.21e-06	1.67e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—ALB—epilepsy syndrome	1.21e-06	1.67e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.21e-06	1.67e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—GPX1—epilepsy syndrome	1.2e-06	1.65e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HES1—epilepsy syndrome	1.19e-06	1.64e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	1.19e-06	1.64e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MMP9—epilepsy syndrome	1.19e-06	1.63e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—FGF2—epilepsy syndrome	1.18e-06	1.63e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AGT—epilepsy syndrome	1.18e-06	1.62e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—POMC—epilepsy syndrome	1.16e-06	1.6e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ABCG2—epilepsy syndrome	1.16e-06	1.6e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—FYN—epilepsy syndrome	1.16e-06	1.59e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP2D6—epilepsy syndrome	1.16e-06	1.59e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—APOE—epilepsy syndrome	1.15e-06	1.59e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—H2AFX—epilepsy syndrome	1.15e-06	1.59e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	1.15e-06	1.59e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—ALB—epilepsy syndrome	1.15e-06	1.58e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.14e-06	1.57e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	1.13e-06	1.56e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	1.12e-06	1.55e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—YWHAZ—epilepsy syndrome	1.11e-06	1.53e-05	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—AKT1—epilepsy syndrome	1.11e-06	1.53e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—FGF2—epilepsy syndrome	1.1e-06	1.52e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ADRA2A—epilepsy syndrome	1.1e-06	1.52e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—RELA—epilepsy syndrome	1.1e-06	1.51e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—BCHE—epilepsy syndrome	1.1e-06	1.51e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—SRC—epilepsy syndrome	1.09e-06	1.51e-05	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	1.09e-06	1.5e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	1.08e-06	1.49e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—POMC—epilepsy syndrome	1.08e-06	1.49e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—POMC—epilepsy syndrome	1.08e-06	1.49e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MTOR—epilepsy syndrome	1.08e-06	1.48e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	1.07e-06	1.47e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CCR5—epilepsy syndrome	1.07e-06	1.47e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—VEGFA—epilepsy syndrome	1.07e-06	1.47e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—HMOX1—epilepsy syndrome	1.06e-06	1.47e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTGS2—epilepsy syndrome	1.06e-06	1.46e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTGS2—epilepsy syndrome	1.06e-06	1.46e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—ALB—epilepsy syndrome	1.06e-06	1.46e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	1.06e-06	1.45e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CAT—epilepsy syndrome	1.05e-06	1.45e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	1.05e-06	1.45e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AGT—epilepsy syndrome	1.05e-06	1.44e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—SLC2A1—epilepsy syndrome	1.05e-06	1.44e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—POMC—epilepsy syndrome	1.04e-06	1.44e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.04e-06	1.44e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.04e-06	1.44e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	1.04e-06	1.43e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PLCB1—epilepsy syndrome	1.03e-06	1.43e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—TH—epilepsy syndrome	1.03e-06	1.42e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—APOE—epilepsy syndrome	1.03e-06	1.42e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ABCB1—epilepsy syndrome	1.02e-06	1.41e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.02e-06	1.4e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	1.01e-06	1.4e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—epilepsy syndrome	1e-06	1.38e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MTOR—epilepsy syndrome	1e-06	1.38e-05	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—AKT1—epilepsy syndrome	9.99e-07	1.38e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TSC2—epilepsy syndrome	9.95e-07	1.37e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—epilepsy syndrome	9.94e-07	1.37e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—POMC—epilepsy syndrome	9.92e-07	1.37e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CASP3—epilepsy syndrome	9.9e-07	1.36e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	9.89e-07	1.36e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ALB—epilepsy syndrome	9.87e-07	1.36e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ALB—epilepsy syndrome	9.87e-07	1.36e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—BCHE—epilepsy syndrome	9.85e-07	1.36e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—APOE—epilepsy syndrome	9.74e-07	1.34e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—AKT1—epilepsy syndrome	9.71e-07	1.34e-05	CbGpPWpGaD
Indomethacin—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	9.67e-07	1.33e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	9.65e-07	1.33e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—JUN—epilepsy syndrome	9.62e-07	1.33e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—BCHE—epilepsy syndrome	9.61e-07	1.32e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ALB—epilepsy syndrome	9.52e-07	1.31e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	9.5e-07	1.31e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GPX1—epilepsy syndrome	9.49e-07	1.31e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	9.47e-07	1.3e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—AKT1—epilepsy syndrome	9.45e-07	1.3e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	9.39e-07	1.29e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MMP9—epilepsy syndrome	9.36e-07	1.29e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	9.29e-07	1.28e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—TH—epilepsy syndrome	9.26e-07	1.28e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—epilepsy syndrome	9.25e-07	1.27e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	9.17e-07	1.26e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—IL6ST—epilepsy syndrome	9.15e-07	1.26e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	9.11e-07	1.26e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AKT1—epilepsy syndrome	9.08e-07	1.25e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOS2—epilepsy syndrome	9.07e-07	1.25e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PLCB1—epilepsy syndrome	9.07e-07	1.25e-05	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—AKT1—epilepsy syndrome	9.06e-07	1.25e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ALB—epilepsy syndrome	9.05e-07	1.25e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—TH—epilepsy syndrome	9.04e-07	1.24e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—SRC—epilepsy syndrome	9.02e-07	1.24e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	9.02e-07	1.24e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—BCHE—epilepsy syndrome	8.98e-07	1.24e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—POMC—epilepsy syndrome	8.83e-07	1.22e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—epilepsy syndrome	8.78e-07	1.21e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—epilepsy syndrome	8.64e-07	1.19e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—epilepsy syndrome	8.64e-07	1.19e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SRC—epilepsy syndrome	8.63e-07	1.19e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—HMOX1—epilepsy syndrome	8.61e-07	1.19e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	8.56e-07	1.18e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CAT—epilepsy syndrome	8.49e-07	1.17e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	8.47e-07	1.17e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TH—epilepsy syndrome	8.44e-07	1.16e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—epilepsy syndrome	8.4e-07	1.16e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—epilepsy syndrome	8.33e-07	1.15e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AGT—epilepsy syndrome	8.32e-07	1.15e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.31e-07	1.14e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ABCB1—epilepsy syndrome	8.26e-07	1.14e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—APOE—epilepsy syndrome	8.16e-07	1.12e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AKT1—epilepsy syndrome	8.13e-07	1.12e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ALB—epilepsy syndrome	8.05e-07	1.11e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SRC—epilepsy syndrome	8.04e-07	1.11e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—epilepsy syndrome	7.91e-07	1.09e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	7.73e-07	1.06e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GPX1—epilepsy syndrome	7.68e-07	1.06e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CAT—epilepsy syndrome	7.62e-07	1.05e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HMOX1—epilepsy syndrome	7.54e-07	1.04e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CAT—epilepsy syndrome	7.44e-07	1.03e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	7.42e-07	1.02e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—FGF2—epilepsy syndrome	7.4e-07	1.02e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AKT1—epilepsy syndrome	7.05e-07	9.71e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	7.04e-07	9.71e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—epilepsy syndrome	7.04e-07	9.7e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—POMC—epilepsy syndrome	7.01e-07	9.65e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CAT—epilepsy syndrome	6.95e-07	9.58e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GPX1—epilepsy syndrome	6.89e-07	9.5e-06	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT1—epilepsy syndrome	6.8e-07	9.36e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	6.76e-07	9.32e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MTOR—epilepsy syndrome	6.73e-07	9.28e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AGT—epilepsy syndrome	6.73e-07	9.28e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GPX1—epilepsy syndrome	6.73e-07	9.27e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—APOE—epilepsy syndrome	6.6e-07	9.09e-06	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—AKT1—epilepsy syndrome	6.5e-07	8.95e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ALB—epilepsy syndrome	6.39e-07	8.8e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GPX1—epilepsy syndrome	6.29e-07	8.66e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AGT—epilepsy syndrome	6.05e-07	8.33e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—APOE—epilepsy syndrome	5.92e-07	8.16e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AGT—epilepsy syndrome	5.9e-07	8.13e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—APOE—epilepsy syndrome	5.78e-07	7.96e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—POMC—epilepsy syndrome	5.67e-07	7.81e-06	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT1—epilepsy syndrome	5.6e-07	7.72e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AGT—epilepsy syndrome	5.51e-07	7.59e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—APOE—epilepsy syndrome	5.4e-07	7.44e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SRC—epilepsy syndrome	5.4e-07	7.43e-06	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT1—epilepsy syndrome	5.36e-07	7.39e-06	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AKT1—epilepsy syndrome	5.34e-07	7.36e-06	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AKT1—epilepsy syndrome	5.34e-07	7.36e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—POMC—epilepsy syndrome	5.09e-07	7.01e-06	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AKT1—epilepsy syndrome	5.05e-07	6.96e-06	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT1—epilepsy syndrome	5e-07	6.88e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—POMC—epilepsy syndrome	4.97e-07	6.84e-06	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AKT1—epilepsy syndrome	4.65e-07	6.41e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—POMC—epilepsy syndrome	4.64e-07	6.39e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ALB—epilepsy syndrome	4.64e-07	6.39e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ALB—epilepsy syndrome	4.53e-07	6.24e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—epilepsy syndrome	4.52e-07	6.23e-06	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AKT1—epilepsy syndrome	4.34e-07	5.98e-06	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AKT1—epilepsy syndrome	4.34e-07	5.98e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ALB—epilepsy syndrome	4.23e-07	5.83e-06	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AKT1—epilepsy syndrome	4.19e-07	5.77e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	4.06e-07	5.59e-06	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AKT1—epilepsy syndrome	3.98e-07	5.48e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—epilepsy syndrome	3.96e-07	5.46e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	3.7e-07	5.1e-06	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AKT1—epilepsy syndrome	3.54e-07	4.87e-06	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT1—epilepsy syndrome	3.35e-07	4.62e-06	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKT1—epilepsy syndrome	2.81e-07	3.87e-06	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKT1—epilepsy syndrome	2.27e-07	3.13e-06	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKT1—epilepsy syndrome	2.04e-07	2.81e-06	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.99e-07	2.74e-06	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKT1—epilepsy syndrome	1.86e-07	2.56e-06	CbGpPWpGaD
